Literature DB >> 4094420

1,2-Diaryl-3,4-dihydronaphthalenes: photofluorogenic ligands for the estrogen receptor.

R D Bindal, J A Katzenellenbogen.   

Abstract

1,2-Diaryl-3,4-dihydronaphthalene systems related to the Upjohn antiestrogen nafoxidine (U11, 110A) (1) have high affinity for the estrogen receptor, but are essentially non-fluorescent. Upon u.v. irradiation, however, the cis-stilbene system within their structure undergo a photocyclization (2) followed by a spontaneous oxidation, forming a dihydrobenzochrysene system (3) that is highly fluorescent, but is only weakly bound by the estrogen receptor. This system can be oxidized further to the benzochrysene system, which exhibits similar fluorescence. The 1,2-diarylnaphthalene systems, obtained by direct oxidation of the dihydronaphthalenes, however, do not undergo photocyclization. The binding affinity of these derivatives for the estrogen receptor appears to be related to their degree of non-planarity and can be correlated with their molecular surface area. This facile photochemical conversion of a high-affinity ligand to a highly fluorescent species offers a new approach to the design of fluorescent estrogens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4094420     DOI: 10.1016/0022-4731(85)90049-4

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  4 in total

1.  Kinetic analysis of estrogen receptor/ligand interactions.

Authors:  Rebecca L Rich; Lise R Hoth; Kieran F Geoghegan; Thomas A Brown; Peter K LeMotte; Samuel P Simons; Preston Hensley; David G Myszka
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

2.  Lasofoxifene: Evidence of its therapeutic value in osteoporosis.

Authors:  Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Ranuccio Nuti
Journal:  Core Evid       Date:  2010-06-15

Review 3.  Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene.

Authors:  Luigi Gennari; Daniela Merlotti; Ranuccio Nuti
Journal:  Clin Interv Aging       Date:  2010-02-02       Impact factor: 4.458

Review 4.  Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.

Authors:  Luigi Gennari; Daniela Merlotti; Fabrizio Valleggi; Giuseppe Martini; Ranuccio Nuti
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.